Where could CDNA trade next? Consensus target price: $50.
Get informed when a big investor buys or sells
+ Follow$49.6
5 analysts in the last 4 months
High: $64 | Low: $35
No recommendations in the last 4 months.
Caredx posts a target price of $50. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
A target price of $50 for CDNA means covering analysts, on average, see the stock 0.8% upside of $49.6 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.
Context for CDNA's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Caredx's other metric pages and overview cover the third.
Judging Caredx against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $50 here, then scan peer and history charts to see if the gap is persistent.